title: Reduced IL-33 plasma levels in multiple myeloma patients are associated with more advanced stage of disease.
authors.forename: Caterina
authors.initials: C
authors.lastname: Musolino
authors.forename: Alessandro
authors.initials: A
authors.lastname: Allegra
authors.forename: Mirella
authors.initials: M
authors.lastname: Profita
authors.forename: Andrea
authors.initials: A
authors.lastname: Alonci
authors.forename: Salvatore
authors.initials: S
authors.lastname: Saitta
authors.forename: Sabina
authors.initials: S
authors.lastname: Russo
authors.forename: Anna
authors.initials: A
authors.lastname: Bonanno
authors.forename: Vanessa
authors.initials: V
authors.lastname: Innao
authors.forename: Sebastiano
authors.initials: S
authors.lastname: Gangemi
mesh_terms: D000368:Aged; D005260:Female; D006801:Humans; D000067596:Interleukin-33; D007378:Interleukins / Q000097:blood / Q000172:deficiency* / Q000502:physiology; D007676:Kidney Failure, Chronic / Q000097:blood / Q000209:etiology; D008297:Male; D008875:Middle Aged; D008998:Monoclonal Gammopathy of Undetermined Significance / Q000097:blood; D009101:Multiple Myeloma / Q000097:blood* / Q000150:complications / Q000276:immunology / Q000473:pathology; D009194:Myeloma Proteins / Q000032:analysis; D009367:Neoplasm Staging; D010014:Osteolysis / Q000097:blood / Q000209:etiology
chemical_list: C506536:IL33 protein, human; D000067596:Interleukin-33; D007378:Interleukins; D009194:Myeloma Proteins